Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42255,232,1.01 [0.89-1.13],0.9305612456666564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43718,334,0.99 [0.89-1.09],0.795456181496147
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43282,2299,1.03 [0.99-1.07],0.1964527600962848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43756,722,0.98 [0.91-1.05],0.513631490851991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42429,5872,1.02 [0.99-1.04],0.1597502783822958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42619,5321,1.00 [0.97-1.02],0.8494708489968135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,43333,2023,1.02 [0.98-1.06],0.318320545356664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43601,149,0.92 [0.79-1.07],0.2844143680758256
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40336,1588,0.99 [0.95-1.04],0.7294763382464408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38929,1776,1.00 [0.95-1.04],0.8803962196618378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38800,424,0.99 [0.90-1.08],0.7494612092846944
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30724,3281,0.99 [0.96-1.02],0.5525684566400342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38543,640,1.03 [0.96-1.11],0.3588569572557637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43691,2381,1.01 [0.98-1.05],0.4858487445849654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,43883,849,0.97 [0.91-1.04],0.4072893664812483
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42520,1537,1.01 [0.96-1.06],0.7429900325103349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43774,1751,0.99 [0.95-1.03],0.6378245250709802
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41646,336,0.99 [0.89-1.09],0.7918603989236511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43975,78,1.02 [0.83-1.25],0.8720147196892027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43557,1534,0.99 [0.94-1.04],0.6742079456154888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43580,128,1.06 [0.91-1.25],0.451675697578076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43829,265,1.09 [0.98-1.22],0.1171653264971769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43800,236,1.13 [1.00-1.27],0.0428041276165438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41671,688,1.10 [1.03-1.18],0.0054909479933047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41440,457,1.00 [0.92-1.09],0.9990703164317872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41478,168,1.06 [0.92-1.22],0.4315746090006324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43935,91,0.94 [0.77-1.13],0.4938467732315506
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43861,257,0.98 [0.88-1.10],0.7585712229092271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,43690,86,1.07 [0.88-1.31],0.4729136580953023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43715,111,0.93 [0.78-1.10],0.3889075213984773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,43477,499,1.06 [0.98-1.15],0.1700248655134457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43826,99,1.08 [0.90-1.30],0.3955630199446733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43785,106,1.16 [0.97-1.38],0.1015018485408047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20167,108,0.99 [0.83-1.19],0.9498973671964576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43400,2416,0.98 [0.94-1.02],0.2406274361470182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,43949,100,1.02 [0.85-1.22],0.8722370237643694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43865,112,0.99 [0.83-1.18],0.9181699962937564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43931,181,1.08 [0.94-1.24],0.2554435451918864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,23704,147,1.07 [0.92-1.24],0.3978414961589576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43932,620,0.95 [0.88-1.02],0.1911048609666483
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,43942,505,0.99 [0.92-1.08],0.8739986571776863
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43781,118,1.03 [0.87-1.22],0.6900324571654572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43933,369,0.92 [0.83-1.01],0.072016852704155
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,43857,604,0.95 [0.88-1.02],0.152551384616312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43771,1054,0.98 [0.93-1.04],0.5055043418702654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43925,715,0.96 [0.89-1.02],0.1887634071702129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,19223,122,0.83 [0.71-0.98],0.0301116094570559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19295,142,0.94 [0.81-1.10],0.4358679826494076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",35020,92,1.00 [0.83-1.21],0.9784164192548644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",35045,117,0.87 [0.74-1.04],0.1190891691200014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43883,201,0.96 [0.84-1.09],0.4813628132414991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",43884,196,0.95 [0.84-1.09],0.4776785061539936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Leiomyoma of uterus,22914,498,1.00 [0.92-1.08],0.9239985069360672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,30525,582,0.96 [0.89-1.03],0.2379390208979799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lymphoid leukaemia,35019,91,1.05 [0.86-1.27],0.6371986686358724
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35248,320,1.10 [0.99-1.21],0.0746054349752557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35263,335,0.97 [0.88-1.07],0.5610987966266985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19422,163,0.95 [0.82-1.09],0.4534494406158988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",35066,138,0.96 [0.82-1.13],0.6544116560055098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",35104,176,1.03 [0.89-1.18],0.7025179330953004
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",35099,171,0.96 [0.83-1.10],0.5626975083209741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19389,130,1.02 [0.87-1.20],0.789870016922667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",35088,160,1.03 [0.89-1.19],0.7173485043476182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16839,1170,0.97 [0.92-1.03],0.3262336817967516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35125,197,0.93 [0.81-1.06],0.2539692080991896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",35060,132,1.03 [0.88-1.21],0.7028443800175819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,35099,171,1.01 [0.87-1.16],0.9339536589906962
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,43643,351,1.05 [0.95-1.16],0.3122533029775026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,43911,154,1.10 [0.95-1.28],0.1838430531239534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanoma in situ,34984,139,1.13 [0.97-1.32],0.11383789760019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",35085,157,0.96 [0.83-1.11],0.5795393900705101
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35197,269,0.96 [0.86-1.08],0.5096017556564822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35329,401,0.88 [0.80-0.96],0.0054448373972271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",35092,164,0.95 [0.82-1.09],0.4541906030865348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,43668,276,1.07 [0.96-1.19],0.2548477841767609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36732,1804,0.99 [0.94-1.03],0.4991849089702556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36828,1900,0.99 [0.95-1.04],0.7534483878482088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43461,591,0.98 [0.91-1.06],0.6452925430687761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40829,151,1.00 [0.86-1.17],0.9680809926816925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42998,128,1.12 [0.95-1.31],0.1696755813522905
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42656,4839,1.02 [0.99-1.04],0.1855725295584887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41549,79,1.19 [0.97-1.46],0.0943699159483333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43274,87,0.96 [0.79-1.17],0.6979841775753378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43179,2501,1.01 [0.98-1.05],0.4938073142486593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43177,2499,1.01 [0.98-1.05],0.5155105573006875
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40824,146,0.90 [0.77-1.05],0.1701202369247289
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43429,1959,1.08 [1.04-1.13],0.0001173816714756
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,43380,193,1.02 [0.90-1.17],0.7396744682275966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42979,109,0.85 [0.71-1.01],0.0697236429663722
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42980,110,1.07 [0.90-1.28],0.4200066464462103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43648,461,0.87 [0.79-0.94],0.0010084107957416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43802,93,1.03 [0.86-1.25],0.722033601607958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43569,382,0.80 [0.73-0.88],3.5566458762645334e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41645,175,1.01 [0.88-1.16],0.9107281702885452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34144,506,0.98 [0.90-1.06],0.6281685777528789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40995,193,1.02 [0.89-1.16],0.7793920960154546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,41022,220,0.97 [0.86-1.10],0.6186795107932026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33733,95,1.13 [0.94-1.37],0.1876253964843968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40858,107,1.00 [0.84-1.20],0.9622337509300544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39944,387,0.92 [0.84-1.01],0.0896971955191345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",43208,899,0.95 [0.89-1.01],0.0869531372550683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42769,460,0.91 [0.84-1.00],0.0412282096504267
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42483,174,1.05 [0.92-1.21],0.4771053476113259
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,43392,2641,1.03 [0.99-1.07],0.1107077819410377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38402,2571,1.03 [0.99-1.07],0.1359226680796693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33741,103,0.97 [0.81-1.16],0.7180929545711305
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40636,138,1.06 [0.91-1.23],0.4814695424334734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34104,466,1.04 [0.96-1.13],0.3556548483521315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33737,99,1.10 [0.92-1.32],0.3012369206376876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39590,5952,1.04 [1.01-1.06],0.0022634684078931
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33975,337,0.88 [0.80-0.97],0.0129361305731227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34571,933,0.99 [0.93-1.05],0.6757757337639199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43841,536,1.04 [0.97-1.13],0.2786304492618727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43523,218,1.00 [0.89-1.14],0.9531588492992208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33852,214,0.99 [0.87-1.12],0.8471320454890607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33742,104,0.98 [0.82-1.17],0.7936694072880907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,43070,2572,1.02 [0.98-1.06],0.2844992777141746
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,34065,427,1.02 [0.93-1.11],0.739912828700725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34099,461,0.95 [0.87-1.04],0.2704561486583595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34699,1061,1.06 [1.00-1.12],0.0516570137843574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33820,182,0.93 [0.81-1.07],0.2968896525811513
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43511,206,0.99 [0.87-1.12],0.859114336601041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34651,1013,1.00 [0.94-1.05],0.8810310576663145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34453,815,0.99 [0.92-1.05],0.6702213828012829
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39668,111,1.08 [0.91-1.28],0.3693811312506172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42050,8412,1.02 [1.00-1.04],0.0669650987540167
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40573,75,0.94 [0.77-1.16],0.5778954709488706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40596,98,1.02 [0.85-1.23],0.8212465862182765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43667,3257,0.98 [0.95-1.02],0.3015256793977177
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43667,3251,0.98 [0.95-1.02],0.309679695555157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40583,85,1.03 [0.84-1.25],0.7981250193203109
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,43392,2048,1.04 [1.00-1.08],0.061937275784026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36271,2633,1.00 [0.96-1.03],0.8171149749584552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43956,352,0.92 [0.84-1.02],0.1060660396164989
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42437,128,0.88 [0.75-1.04],0.1403839664465284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41524,180,1.02 [0.89-1.17],0.7999351176223468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41585,241,1.18 [1.05-1.32],0.005796045838427
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33911,273,1.05 [0.94-1.18],0.3534251307794661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40040,265,1.03 [0.92-1.16],0.5690661342105796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3618,140,0.97 [0.83-1.14],0.7254424113652861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3845,412,1.00 [0.91-1.09],0.9273074249367304
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39882,107,1.11 [0.93-1.33],0.2304812583322459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3559,82,1.00 [0.81-1.23],0.9857738762076552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42925,3150,1.02 [0.99-1.06],0.2018332623853839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42874,565,0.90 [0.83-0.97],0.0069563786667711
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40171,614,0.98 [0.91-1.05],0.5480485847107661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34885,1247,0.99 [0.94-1.04],0.6248290813485906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43780,410,0.86 [0.79-0.94],0.001256323182572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),42069,270,0.84 [0.75-0.94],0.0023407614585047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,40232,2000,1.01 [0.97-1.05],0.729407926936258
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,42203,404,0.86 [0.78-0.94],0.0010269536040106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41897,98,1.03 [0.85-1.24],0.76940923818078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",42129,330,1.00 [0.90-1.11],0.9983523053860984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27263,3173,0.97 [0.94-1.00],0.0850339660925005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,AV-block,37147,714,1.00 [0.93-1.07],0.9926558940052238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43873,697,0.97 [0.90-1.04],0.3490531554431281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24408,318,1.05 [0.94-1.16],0.3865086154886793
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36723,290,0.88 [0.79-0.98],0.0195474703619066
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36595,162,0.98 [0.85-1.13],0.8213833010868914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43971,76,0.92 [0.74-1.14],0.4337459291267916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,38185,1752,1.00 [0.96-1.05],0.9054459681110648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41694,3494,1.01 [0.98-1.05],0.3614737811791161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38498,12927,1.00 [0.99-1.02],0.5735701398329704
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41645,443,0.88 [0.81-0.96],0.0055099368333224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,36552,119,0.93 [0.79-1.10],0.4077428814878346
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43622,1828,1.02 [0.98-1.06],0.3796105781168193
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,40049,11060,1.01 [0.99-1.03],0.1767131226320277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",40062,11073,1.01 [0.99-1.03],0.1903645737768735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43675,132,0.77 [0.65-0.90],0.0013500688360353
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29310,321,1.02 [0.92-1.13],0.6604450839466611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29157,168,1.00 [0.87-1.16],0.9597014910964516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,43735,1920,1.00 [0.96-1.05],0.8958762111468958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42428,182,0.89 [0.78-1.02],0.0970169346967872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41998,3766,1.02 [0.99-1.05],0.1932936407372617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43361,955,1.01 [0.95-1.07],0.8369141192130886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,37042,609,1.02 [0.95-1.10],0.5505102714863003
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43197,1415,1.03 [0.98-1.08],0.262042164956138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39424,1192,1.05 [1.00-1.11],0.0666350280232324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43815,265,1.12 [1.00-1.25],0.0483885437562841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43923,518,1.04 [0.96-1.12],0.3627177046522484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,41288,86,0.79 [0.64-0.96],0.0190809064319872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,41927,128,0.99 [0.84-1.16],0.9009003120812622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,37157,724,1.02 [0.96-1.10],0.4838332258568032
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41970,171,1.05 [0.91-1.20],0.5165119465503689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42197,398,0.94 [0.86-1.03],0.1691142377186953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36735,302,0.98 [0.88-1.09],0.6950710665618958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,41351,149,0.93 [0.80-1.08],0.366012231109329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41282,80,1.01 [0.83-1.24],0.8995358220817076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41578,103,1.00 [0.83-1.19],0.9638154703496152
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41421,219,0.96 [0.84-1.09],0.4991179327814169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,38145,1712,1.00 [0.95-1.04],0.8854714296904813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41906,91,0.82 [0.67-0.99],0.0429198206745035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42713,914,0.98 [0.92-1.04],0.4275561029964047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42927,604,1.01 [0.94-1.09],0.7244437588597958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42491,1016,0.98 [0.92-1.04],0.4478410904752706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24648,558,0.98 [0.90-1.06],0.5668073965764036
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42420,675,0.99 [0.92-1.06],0.7353358933354985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41776,574,0.91 [0.84-0.98],0.0186627827313897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43122,799,0.99 [0.93-1.06],0.7761050881730324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43848,1090,0.99 [0.94-1.05],0.7195672185600561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,37010,577,0.99 [0.92-1.07],0.7916378567090784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42919,596,1.01 [0.94-1.09],0.7155875407315911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41794,319,0.94 [0.85-1.04],0.2536594776157543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43338,1092,0.99 [0.94-1.05],0.7763748362243197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43302,1156,0.99 [0.94-1.04],0.7155340419349174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,42380,100,0.97 [0.81-1.17],0.762915613032135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41931,133,0.86 [0.74-1.01],0.0725585212413988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42784,378,1.06 [0.97-1.17],0.2008163067622498
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42217,435,1.01 [0.93-1.10],0.7998201076787257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,41904,702,0.99 [0.92-1.06],0.7469461208602965
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41825,145,0.85 [0.73-0.99],0.0322321334559125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43587,1249,0.95 [0.91-1.00],0.0720586576021118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43764,619,0.96 [0.90-1.04],0.3371586727513821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38522,2415,1.04 [1.01-1.08],0.0217465060228703
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,42873,6766,1.01 [0.99-1.04],0.2577058085568443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43686,722,0.96 [0.90-1.03],0.2916547876180536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38798,2691,1.03 [1.00-1.07],0.0918078296465836
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36245,138,1.00 [0.86-1.17],0.9798088655376505
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,43058,2331,1.02 [0.98-1.06],0.4068081840960902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38882,2775,1.01 [0.98-1.05],0.5815802651506566
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,43165,213,0.91 [0.80-1.03],0.1349192082767612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,43973,571,0.93 [0.86-1.00],0.0482631169930008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29800,101,0.97 [0.81-1.17],0.7580626733115684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,40962,138,0.94 [0.81-1.10],0.4719766316911807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41666,842,1.04 [0.98-1.11],0.2309543850812374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,43285,379,1.02 [0.93-1.12],0.7337452074661439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43836,524,0.91 [0.84-0.99],0.0211700999450401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,43140,92,1.04 [0.86-1.26],0.6753418143500223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43947,112,0.95 [0.80-1.13],0.5967315941784359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",43022,116,1.00 [0.85-1.19],0.9713366485264342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,41373,483,0.98 [0.90-1.06],0.5520588637722326
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43165,2275,1.02 [0.98-1.06],0.2568503630264516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43899,704,0.96 [0.90-1.03],0.2602150667669246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42967,4289,0.95 [0.93-0.98],0.0008787022128256
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,43333,91,1.07 [0.88-1.29],0.4953013082876454
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,43724,412,0.93 [0.85-1.02],0.1328822329599797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,43010,104,1.05 [0.88-1.25],0.6005939594452465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43942,118,1.11 [0.94-1.31],0.2260765665655974
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40957,133,0.92 [0.79-1.08],0.3053004197635608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40957,133,1.04 [0.89-1.21],0.6542396241985191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Memory loss,42920,197,0.96 [0.85-1.10],0.5905176176797338
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,41491,601,1.07 [0.99-1.15],0.073877010932955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43857,545,1.07 [0.99-1.15],0.0928762496045067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,29992,255,1.06 [0.95-1.19],0.3093170172246721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43676,184,0.94 [0.82-1.07],0.3223429957144187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42843,2019,1.02 [0.98-1.06],0.3277238675630602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,41450,6181,1.00 [0.97-1.02],0.8003095779377001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,43360,312,0.97 [0.87-1.07],0.5383195008767779
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41501,677,1.04 [0.97-1.12],0.2646087794263186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43843,487,1.02 [0.94-1.11],0.6663472476021413
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35180,1090,0.95 [0.90-1.00],0.0660773836711599
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,43027,121,0.87 [0.74-1.03],0.110666549465226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,43142,236,0.90 [0.80-1.01],0.0745993436733362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43447,252,0.98 [0.88-1.10],0.7583570251054387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40987,163,0.96 [0.83-1.10],0.5376256754939384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,40990,100,1.03 [0.86-1.24],0.7179440789197682
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,43773,867,1.01 [0.95-1.07],0.8011360411134254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,41818,928,1.01 [0.95-1.07],0.752661307354225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,43931,414,0.94 [0.86-1.03],0.2156847833544443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,43002,96,1.03 [0.86-1.24],0.7551941139672631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43971,114,1.01 [0.85-1.19],0.9474527923803944
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,43576,809,1.00 [0.94-1.07],0.9941136061024988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,43438,82,1.10 [0.90-1.34],0.3737174940440041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43946,299,1.01 [0.91-1.12],0.9101792733066736
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40911,87,1.05 [0.86-1.27],0.6385962662507508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43973,577,0.93 [0.86-1.00],0.0527103406700667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),43099,206,0.91 [0.80-1.04],0.1739394780380144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,43012,162,0.98 [0.85-1.13],0.8163928710987534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43285,674,0.97 [0.91-1.04],0.4278169127016492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43694,384,0.98 [0.89-1.08],0.694807805227567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42265,89,1.00 [0.82-1.21],0.9965263639641544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42279,103,1.24 [1.04-1.48],0.0174251447536228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43790,92,1.04 [0.86-1.26],0.6912070908571079
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43536,250,0.98 [0.87-1.10],0.6958120038309223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3566,88,1.01 [0.83-1.23],0.930043515416091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4304,163,0.99 [0.86-1.15],0.895799464582361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,43014,164,1.07 [0.93-1.23],0.3620277108534304
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43629,1750,1.04 [0.99-1.08],0.0988496199722573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43342,1166,0.98 [0.93-1.04],0.5385687395787337
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42547,371,1.00 [0.91-1.10],0.9709953040560028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43834,1223,1.00 [0.95-1.06],0.9330868309047606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43959,115,1.02 [0.86-1.21],0.7799699490116405
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43712,1101,1.00 [0.94-1.05],0.8774340240731983
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43902,616,1.01 [0.94-1.09],0.7316728003244354
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43811,309,0.96 [0.86-1.06],0.4133341407063038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42279,103,1.10 [0.91-1.32],0.3270016770369829
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42292,116,1.04 [0.88-1.23],0.6666117895000749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42267,91,1.03 [0.85-1.24],0.7863329545927342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43816,1189,1.01 [0.96-1.07],0.6270052844294536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42938,311,0.94 [0.84-1.04],0.2185757797411732
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42692,81,0.93 [0.76-1.14],0.5015021673321901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43456,170,1.05 [0.91-1.21],0.4893402690497987
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43746,460,0.99 [0.90-1.07],0.7310150450191752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42935,324,1.02 [0.92-1.13],0.6682942442014697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43688,186,0.97 [0.85-1.10],0.6218372683816731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43401,774,1.03 [0.97-1.10],0.3436586423905314
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,43082,232,1.03 [0.91-1.16],0.6626606015406219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41271,3711,1.03 [1.00-1.06],0.0853677835211484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43690,404,0.98 [0.90-1.07],0.6836632792917761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43936,260,1.08 [0.97-1.21],0.176682990347999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42868,692,0.98 [0.91-1.05],0.4989646352732734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43401,115,1.07 [0.90-1.26],0.461145418912352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43937,93,1.11 [0.92-1.35],0.2585870632569013
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42320,144,0.91 [0.78-1.07],0.2564027056568884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42431,255,0.87 [0.78-0.98],0.0211453132443917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,42076,197,1.07 [0.94-1.21],0.3349725986615771
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42708,97,1.05 [0.87-1.26],0.6062151404344773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41991,112,0.93 [0.78-1.11],0.4172721740954814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42773,146,1.00 [0.86-1.16],0.9536291525131813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42951,324,1.01 [0.91-1.11],0.9073557012155206
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,42380,204,1.03 [0.91-1.17],0.6315535612793244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,42067,188,1.23 [1.08-1.40],0.0017660735464891
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,42013,134,1.10 [0.94-1.29],0.2362763209168185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40592,3032,1.00 [0.97-1.04],0.9012234651921824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42297,121,1.01 [0.85-1.19],0.94907062524123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43542,692,1.01 [0.94-1.08],0.7677185587376163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42949,99,0.95 [0.79-1.14],0.5986340100717006
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),43124,274,1.04 [0.93-1.16],0.4731877896559009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43593,153,0.93 [0.81-1.08],0.3566788997556616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43900,197,1.06 [0.93-1.20],0.396899186212319
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43753,219,1.03 [0.91-1.17],0.6045006963064452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43550,110,1.00 [0.84-1.19],0.9833291493449914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,43551,111,1.05 [0.88-1.25],0.5823691572615826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43795,1489,1.03 [0.99-1.08],0.1761604335628938
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,43371,1065,1.04 [0.99-1.10],0.1304479993262034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42519,213,0.96 [0.85-1.09],0.5152969561975737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42446,140,1.15 [0.99-1.34],0.071485970160668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,43551,120,0.85 [0.72-1.01],0.0618168781606779
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43794,363,0.92 [0.84-1.01],0.0874103596282451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43537,106,0.85 [0.71-1.02],0.0765836912374712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza,40605,197,1.01 [0.88-1.15],0.9247992866697696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40601,193,1.02 [0.90-1.17],0.7277250969462001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),30147,204,1.06 [0.93-1.20],0.3915393842604885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43763,485,1.10 [1.01-1.19],0.0224866623216801
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32534,3041,1.02 [0.99-1.05],0.2677818811514471
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32937,2994,1.02 [0.99-1.05],0.2525427585900502
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43285,236,1.07 [0.95-1.20],0.2821692499949544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40544,136,1.12 [0.96-1.30],0.1663233845275873
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,38069,589,1.06 [0.98-1.14],0.1361201643721441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37576,96,1.12 [0.93-1.34],0.236335248878629
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42243,4763,1.01 [0.98-1.04],0.4622924910920329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41617,128,0.96 [0.82-1.13],0.6060292991444476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41747,258,1.07 [0.96-1.20],0.2424958284834213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43635,1999,0.99 [0.95-1.03],0.4992314107433129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41679,190,0.98 [0.86-1.12],0.8192052151341342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40427,8899,1.01 [0.99-1.03],0.2108572554541083
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42122,633,1.02 [0.95-1.09],0.6303053425768832
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,42187,551,0.98 [0.91-1.06],0.5781917111680166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Emphysema,38015,535,1.02 [0.95-1.11],0.5672195302629099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41708,506,0.98 [0.91-1.07],0.7132870349057487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43590,3182,1.00 [0.97-1.03],0.9099688088881156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41765,563,1.01 [0.94-1.09],0.7919910139683608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,42236,1448,0.99 [0.95-1.04],0.7842543431716407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43949,520,0.95 [0.88-1.03],0.2511710548129888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,41677,188,0.98 [0.86-1.12],0.7682996874955493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43541,1623,1.00 [0.96-1.05],0.8653644557238568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,43566,3366,1.01 [0.98-1.05],0.3564686635860452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42926,1437,1.05 [1.00-1.10],0.0510901397400402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,40286,86,0.88 [0.73-1.08],0.2171018894910648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43805,695,1.00 [0.93-1.07],0.9647252404933022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43785,2197,1.04 [1.00-1.08],0.0362463474255959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,41859,1659,1.00 [0.95-1.04],0.8332765512208491
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,40473,273,0.99 [0.89-1.11],0.9157667405759476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",43164,2756,1.00 [0.97-1.03],0.9708773755522884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43835,406,0.98 [0.89-1.07],0.6225997345163803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,40408,208,0.93 [0.82-1.05],0.2441876082866221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,43934,413,1.12 [1.02-1.22],0.0136321303677611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,43220,110,0.88 [0.74-1.05],0.1619721090873264
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,30034,91,1.23 [1.02-1.49],0.0325716778183205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43505,1587,1.00 [0.96-1.05],0.976932350910257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41975,486,1.10 [1.02-1.20],0.0184834491704223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,40816,408,1.02 [0.93-1.11],0.73540649256022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",43311,336,0.97 [0.88-1.07],0.5578264905522323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20308,188,0.97 [0.85-1.11],0.6803368065625404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31150,108,1.00 [0.84-1.19],0.9666562452843744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,43690,242,0.94 [0.83-1.05],0.28462682293777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,33157,144,1.01 [0.87-1.18],0.8533034999291172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40856,320,0.98 [0.88-1.08],0.6858800593256038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,43158,153,1.04 [0.89-1.20],0.6356443302368886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,42463,126,0.83 [0.70-0.97],0.023165478302089
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33743,730,1.00 [0.93-1.07],0.9676052383017228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40704,168,1.07 [0.93-1.23],0.3507587525978137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43259,168,1.07 [0.93-1.23],0.3623815263643412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,40868,332,0.95 [0.86-1.05],0.3380580866656437
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,42255,1719,1.00 [0.96-1.04],0.9570458009519496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,33526,513,1.01 [0.93-1.09],0.7941853067672698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40620,84,0.85 [0.70-1.04],0.1250070608294839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43721,178,0.79 [0.68-0.90],0.0007412984219226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,41264,194,1.08 [0.95-1.23],0.2226024464905355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,41112,131,0.93 [0.79-1.09],0.3488031207721395
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43706,326,0.99 [0.89-1.09],0.8397373634725345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,43541,2777,1.00 [0.97-1.03],0.988639893633091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,41133,152,0.92 [0.80-1.07],0.296823880381768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43366,110,0.89 [0.75-1.06],0.1883098084459829
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41123,142,0.99 [0.85-1.15],0.8878029327703729
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,42705,390,1.04 [0.95-1.14],0.3780699074281479
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39487,3726,1.01 [0.98-1.04],0.3703138298064794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,43755,307,0.98 [0.89-1.09],0.7248505367070357
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,43766,1429,0.95 [0.91-1.00],0.046283091920911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40284,7271,1.00 [0.97-1.02],0.6938225196314907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43256,941,1.03 [0.97-1.09],0.3118397185349388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43823,818,1.01 [0.95-1.08],0.6666028070402221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42510,195,1.08 [0.95-1.23],0.22621006495362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,42262,106,1.00 [0.84-1.19],0.988755895469134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,43457,2387,1.00 [0.96-1.03],0.8242258187863812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,42277,188,1.06 [0.93-1.21],0.416931674954893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42938,2402,0.99 [0.96-1.03],0.7549090531572192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36401,5359,1.00 [0.97-1.02],0.7034752280210095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,33348,335,0.98 [0.88-1.08],0.6399577127184621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43821,266,0.97 [0.87-1.08],0.5941821178023429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43829,90,1.27 [1.05-1.53],0.0128547347401418
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42552,215,0.85 [0.75-0.97],0.0130300883782718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31294,252,1.02 [0.91-1.14],0.7253811133483734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33949,936,1.03 [0.97-1.09],0.3719578995263468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,33626,613,0.98 [0.91-1.05],0.584897297418908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37232,4219,1.00 [0.97-1.03],0.96411984859859
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33926,913,0.98 [0.93-1.05],0.6061639290234773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34067,14020,1.00 [0.98-1.01],0.6103583980483622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,43020,1950,0.98 [0.94-1.02],0.3840260263832062
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42422,107,0.98 [0.82-1.17],0.8496373535570675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32676,2111,1.00 [0.96-1.04],0.9699362222145698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42440,103,0.82 [0.68-0.98],0.0280133609180601
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,41205,5444,1.01 [0.98-1.03],0.4799148470203593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,43840,84,1.32 [1.09-1.60],0.0047711102749026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,31141,99,1.00 [0.83-1.20],0.985027240952842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,37287,1526,0.99 [0.95-1.04],0.7791937260471742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35934,173,0.99 [0.86-1.14],0.891820417119024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31203,161,0.87 [0.76-1.01],0.0640576194768139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41302,232,1.10 [0.98-1.24],0.1047010146415833
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31980,938,1.01 [0.96-1.08],0.6377296938704762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43926,615,1.04 [0.97-1.12],0.3106785305771977
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42248,1267,1.03 [0.98-1.08],0.2705381141919827
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42672,1691,1.01 [0.96-1.05],0.7764004740354826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33327,314,1.00 [0.91-1.11],0.9271856350983688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,34045,1032,1.04 [0.99-1.10],0.1385217430783402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43884,234,1.03 [0.92-1.16],0.6063475029636394
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35875,114,1.06 [0.89-1.26],0.5270662989166068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33332,2290,0.99 [0.95-1.03],0.6455591904253329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41000,464,0.99 [0.91-1.08],0.8409470209619568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40803,267,0.98 [0.88-1.09],0.7122776178622507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,34021,2979,0.99 [0.96-1.02],0.5196836403634447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40559,9517,0.99 [0.97-1.01],0.1677716573686268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42250,353,1.06 [0.96-1.16],0.2653368511374226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,43502,1165,0.95 [0.90-1.01],0.0779334400849851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34129,1116,0.98 [0.93-1.03],0.4097764356648898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40786,250,0.94 [0.84-1.06],0.326147454449336
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43711,706,1.01 [0.94-1.08],0.7558921757426009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34608,1595,0.97 [0.92-1.01],0.1472541369476322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,43045,1975,0.98 [0.94-1.02],0.3604703100777883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42614,299,1.01 [0.91-1.13],0.8028917791131736
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33900,2858,1.00 [0.96-1.03],0.8194786916232963
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36410,3397,0.97 [0.94-1.00],0.0568457759240639
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42505,168,0.84 [0.73-0.97],0.0151022515848035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42461,1480,1.01 [0.96-1.06],0.7781898864684784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31629,587,0.96 [0.89-1.03],0.2550852031249124
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43810,107,1.24 [1.04-1.47],0.0153840010594944
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31876,834,0.94 [0.88-1.00],0.0534295689858475
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41331,261,1.00 [0.89-1.12],0.974172701125104
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43951,99,0.89 [0.74-1.07],0.2244621219360441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,42323,201,1.00 [0.88-1.14],0.939766941595906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,41076,95,0.90 [0.74-1.09],0.2730149920583644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33481,468,1.02 [0.94-1.11],0.5873879311196806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,41255,274,1.00 [0.90-1.12],0.972071460957638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41211,230,1.00 [0.89-1.13],0.97488643979668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,36217,456,0.94 [0.86-1.02],0.1612689546046339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31343,301,0.92 [0.83-1.02],0.1108587760713329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,36197,436,1.03 [0.94-1.12],0.5677063018098532
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Volvulus,31175,133,0.91 [0.78-1.06],0.2341601334546026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43844,485,1.02 [0.94-1.11],0.6264329118014874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43432,137,0.99 [0.85-1.16],0.9298450272448464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40552,271,1.03 [0.92-1.14],0.6549185037687417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42874,1185,0.97 [0.92-1.02],0.2422381920664573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41991,302,1.06 [0.96-1.18],0.2444646593903526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40932,651,0.95 [0.88-1.02],0.1715749834400119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43451,464,1.03 [0.95-1.13],0.4323281827895285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43791,804,1.01 [0.94-1.07],0.8150841735156216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,43070,83,1.01 [0.83-1.23],0.9189950353550989
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41336,5404,1.00 [0.98-1.03],0.9108212889048332
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43195,747,0.99 [0.92-1.06],0.7176217245916797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42966,518,1.01 [0.93-1.09],0.8881085165448607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43298,1609,0.98 [0.94-1.03],0.3929397357862952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43945,90,1.09 [0.90-1.32],0.3880210287462226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40391,110,0.98 [0.83-1.17],0.8621364508218985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42542,94,1.08 [0.90-1.31],0.4070810960960205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43433,446,1.04 [0.95-1.13],0.4225221837783511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41046,765,1.04 [0.98-1.11],0.2019395513159995
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40393,112,0.92 [0.77-1.09],0.3421736887922831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43828,139,0.97 [0.83-1.13],0.6656054856258347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41991,302,1.06 [0.95-1.18],0.2727258145983867
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43622,327,0.90 [0.81-0.99],0.0343719964799934
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,43086,99,0.92 [0.76-1.11],0.3771371406540784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40389,108,0.99 [0.83-1.17],0.8689800984286826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,43009,2728,1.00 [0.96-1.03],0.9151233052594916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41112,831,1.04 [0.98-1.11],0.1998763781444611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40400,119,0.93 [0.79-1.10],0.4042114961671401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43823,528,0.98 [0.91-1.07],0.6922147430421158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,43107,120,0.99 [0.84-1.17],0.8816070878329858
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43730,435,0.97 [0.88-1.05],0.4303014416819534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43888,529,1.02 [0.94-1.11],0.5777596044271693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40494,213,1.08 [0.95-1.22],0.2182976909918811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40732,451,0.99 [0.91-1.08],0.8141981490576549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43870,511,1.01 [0.93-1.10],0.7651866413420322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40665,384,1.03 [0.94-1.14],0.4781315535461531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43920,231,0.99 [0.88-1.12],0.9257053152855548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37709,184,1.03 [0.90-1.18],0.6560152152805796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40020,9555,1.01 [0.99-1.02],0.5515163322710555
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37626,7161,1.01 [0.99-1.04],0.1778830113637599
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37655,130,0.97 [0.83-1.14],0.6940848859639177
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38156,255,0.99 [0.89-1.11],0.9008111141502302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38204,303,1.00 [0.90-1.11],0.984867458555384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43549,157,0.89 [0.77-1.03],0.1274370862743816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",38071,170,0.92 [0.80-1.06],0.2699681369047249
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32396,1931,1.02 [0.98-1.06],0.3611051642535146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43729,323,1.01 [0.91-1.12],0.874223027403598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38628,727,1.03 [0.97-1.11],0.32576413946254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37158,12325,1.00 [0.99-1.02],0.5747046864234611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40597,197,0.96 [0.84-1.09],0.4895466940827743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37785,260,0.98 [0.88-1.10],0.7849466934590312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38509,984,1.04 [0.98-1.10],0.2000375274417257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,42366,4465,1.01 [0.98-1.03],0.6746413572621954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38000,475,1.00 [0.92-1.09],0.9941404064791116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37907,382,1.14 [1.04-1.26],0.0039311426800518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37765,240,1.10 [0.98-1.24],0.1093179981167917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42831,119,0.94 [0.79-1.11],0.4487888207828669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33308,2843,1.01 [0.98-1.05],0.4814459920678683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31450,985,1.03 [0.97-1.10],0.2889555594618538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43839,969,1.03 [0.97-1.10],0.2673406678709556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30594,129,0.99 [0.85-1.16],0.9232161559563368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31037,572,0.92 [0.85-0.99],0.0325723714351218
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38040,515,0.99 [0.92-1.08],0.8840452378560721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31544,1079,1.02 [0.96-1.08],0.4904312176025577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37991,90,1.19 [0.98-1.44],0.0772180237581102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38959,1058,1.03 [0.98-1.09],0.2509230457661662
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38408,507,1.02 [0.94-1.11],0.5717164443222047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31469,1004,1.01 [0.95-1.07],0.7385894853273163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37656,131,1.18 [1.01-1.38],0.0377921862203739
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37625,100,1.06 [0.88-1.26],0.5609281358208585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40521,121,1.03 [0.88-1.22],0.6867474885927118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,43315,2915,0.96 [0.93-0.99],0.0124113757497115
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42315,1915,0.95 [0.92-1.00],0.0281927321112031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43731,771,1.04 [0.97-1.11],0.2421661556336172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34701,4236,1.02 [0.99-1.05],0.2536282530018797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30571,106,0.92 [0.77-1.09],0.3321213474627579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37680,155,1.12 [0.97-1.29],0.1291249961198507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30553,88,0.90 [0.74-1.09],0.2757802140090898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30684,219,0.99 [0.88-1.12],0.9095498028339616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40815,415,0.94 [0.86-1.02],0.1537814984898982
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,41033,633,0.94 [0.87-1.01],0.0820637059658815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43921,167,1.07 [0.93-1.23],0.3417759219905285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40936,3035,1.02 [0.98-1.05],0.2994234612532467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37694,169,1.03 [0.90-1.19],0.647776962324589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30705,240,0.92 [0.81-1.03],0.1463849948049895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,39123,1222,1.02 [0.96-1.07],0.5370221241502281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,34119,3654,1.00 [0.97-1.03],0.8817821658639002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42870,158,0.99 [0.85-1.14],0.84662900178492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43942,130,1.03 [0.88-1.20],0.7399527708375653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37663,138,1.05 [0.90-1.23],0.5337344194826883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39618,2093,1.05 [1.01-1.09],0.0164740961262094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37676,151,0.98 [0.84-1.14],0.769873286329391
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33218,2753,1.04 [1.00-1.07],0.0351227703582523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40597,197,0.95 [0.84-1.09],0.476263824375752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37612,87,1.06 [0.87-1.28],0.5624901332847259
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38167,266,0.93 [0.83-1.05],0.2351694433290401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38436,911,0.99 [0.93-1.05],0.7469007836690853
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43328,616,1.07 [0.99-1.15],0.0914923054359964
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38861,960,1.02 [0.96-1.08],0.4917869124050525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43751,750,1.04 [0.98-1.11],0.2245218453556487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43936,87,1.17 [0.97-1.42],0.1097957298458587
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37848,323,0.97 [0.88-1.08],0.6089395921329308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34808,1269,1.04 [0.99-1.10],0.1200876603105134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38495,970,1.03 [0.97-1.10],0.2683815966596382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37920,395,0.99 [0.90-1.09],0.8488345960236668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30562,97,0.97 [0.80-1.16],0.7287028272554121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34669,4204,1.03 [1.00-1.06],0.0365498325259402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31563,1098,1.00 [0.94-1.05],0.9106316046727936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,43104,392,1.07 [0.98-1.18],0.1457268905133897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43861,107,0.98 [0.82-1.17],0.8551467820312093
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40323,85,1.24 [1.02-1.51],0.0308134929323245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30598,133,1.03 [0.88-1.20],0.7562624865768411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,38074,173,1.09 [0.95-1.26],0.2017393003156426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31246,781,1.05 [0.98-1.12],0.147393189889579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38052,527,1.00 [0.93-1.09],0.9310197518181428
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38330,429,1.08 [0.99-1.18],0.0989471752509287
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38210,309,1.00 [0.90-1.11],0.9925243313636628
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34402,103,1.14 [0.95-1.36],0.1593935502616861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43943,94,1.12 [0.93-1.35],0.2343231112623479
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38523,998,1.02 [0.96-1.08],0.5973092632489581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42878,166,1.06 [0.92-1.22],0.4311875251172341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41900,4375,1.02 [1.00-1.05],0.0877786705835165
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37751,226,0.97 [0.86-1.09],0.5855118760263563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38789,888,1.02 [0.96-1.08],0.5775430348841872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41530,391,0.97 [0.88-1.06],0.5012676788555295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38235,334,1.03 [0.93-1.14],0.5628515789164175
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40495,2594,1.00 [0.96-1.03],0.7873112175052345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39600,1699,1.00 [0.96-1.04],0.9861337501401208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37612,87,1.07 [0.88-1.30],0.4825413400192967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42962,250,0.99 [0.88-1.11],0.8798878629684745
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37804,279,1.08 [0.97-1.21],0.1449720606345092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37659,134,0.87 [0.74-1.02],0.0880162134051112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30559,94,1.08 [0.89-1.30],0.4368783450365178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,42390,2549,0.99 [0.95-1.03],0.5297773867532174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17773,87,1.06 [0.88-1.29],0.5443672931371095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23166,98,0.92 [0.77-1.10],0.3748193559484547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43438,538,1.01 [0.93-1.09],0.8652470508274792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,43042,142,0.89 [0.76-1.03],0.1263693004053334
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,42125,2284,0.97 [0.93-1.00],0.0850450617614433
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43631,106,0.78 [0.65-0.94],0.0086732416915677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43599,493,0.95 [0.87-1.03],0.2167878531925158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,38816,389,0.95 [0.86-1.04],0.2594866802563913
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,39952,111,1.12 [0.94-1.33],0.2087109518062311
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19134,2794,1.03 [0.99-1.06],0.1200043014813911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23352,284,0.98 [0.88-1.09],0.6893171537722946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17837,151,1.02 [0.88-1.18],0.8235046028089408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18023,337,0.92 [0.84-1.02],0.1120119482149249
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18557,871,1.02 [0.96-1.09],0.4522377869226816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36740,8979,0.99 [0.98-1.01],0.5326156875888237
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43653,128,1.08 [0.92-1.27],0.3444175351041574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16515,175,1.10 [0.96-1.27],0.1667893860211637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39796,469,1.02 [0.94-1.11],0.6870535719090702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18537,2197,1.02 [0.98-1.06],0.3274373472597727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23293,347,0.98 [0.89-1.08],0.6647014530296917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16535,195,0.90 [0.79-1.03],0.1249306377085785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23362,108,0.76 [0.64-0.90],0.0017955879463952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17949,263,1.03 [0.92-1.15],0.6109035723845677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38555,128,1.03 [0.88-1.21],0.7376873508056733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19800,2114,0.99 [0.95-1.03],0.5301859098360338
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16436,96,0.93 [0.77-1.12],0.4403563886282997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17804,118,1.03 [0.87-1.22],0.7253304261441451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43957,108,1.01 [0.85-1.21],0.8774138723566822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43957,113,0.86 [0.72-1.02],0.0858188118782413
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42202,3775,0.99 [0.96-1.02],0.3446075720848104
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39642,1215,0.97 [0.92-1.02],0.2938920387201473
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23169,101,0.99 [0.83-1.19],0.9354462167366846
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43863,757,0.98 [0.91-1.04],0.4756587368165061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16600,260,1.01 [0.90-1.13],0.900793597150343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16574,234,0.99 [0.87-1.11],0.8091899164088381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16535,195,1.06 [0.93-1.21],0.3899767932470631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43909,117,0.98 [0.83-1.16],0.8360544412103205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41320,2893,1.00 [0.96-1.03],0.8268277355110598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23126,180,1.04 [0.91-1.19],0.5820582913608701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17818,132,1.14 [0.98-1.33],0.0970970113357685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18020,334,1.01 [0.91-1.11],0.8509764119837984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17789,103,1.07 [0.90-1.28],0.4616716303120753
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17868,182,1.07 [0.93-1.22],0.3453305710666212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39873,546,1.02 [0.94-1.10],0.6056670499271335
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,43354,248,0.98 [0.87-1.10],0.7196170652034262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17946,260,1.03 [0.92-1.15],0.6462060858401578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17777,91,0.86 [0.71-1.04],0.1126281548235839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18235,549,0.98 [0.91-1.06],0.5845836308013191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17823,137,1.11 [0.95-1.30],0.1809417944632244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18192,506,0.95 [0.88-1.03],0.2254471628088565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43611,86,0.92 [0.75-1.12],0.3909504556652912
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16562,222,1.01 [0.89-1.14],0.924254091116478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43611,4284,0.99 [0.96-1.02],0.3828234869233964
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39523,196,1.00 [0.88-1.14],0.9823123615483672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40036,195,0.99 [0.87-1.13],0.9392806742916092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42994,94,1.06 [0.88-1.27],0.5597080443856934
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38806,379,1.00 [0.91-1.10],0.9765948722404412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43571,671,0.99 [0.92-1.06],0.6946272510407984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17805,119,1.07 [0.91-1.26],0.4365623169794729
